NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Sell
28
JANX Quote, Financials, Valuation and Earnings
Last price:
$55.30
Seasonality move
:
84.76%
Day range:
$55.63 - $59.72
52-week range:
$7.79 - $71.71
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
222.56x
P/B ratio:
4.54x
Volume:
1.3M
Avg. volume:
1.3M
1-year change:
495.07%
Market cap:
$3B
Revenue:
$8.1M
EPS (TTM):
-$1.16
Earnings Data
Next earnings date for JANX
May 08
2025
Most recent earnings per share
-$0.51
Missed by $0.15
(Nov 6/2024)
Consensus Estimate
-$0.36
(Nov 6/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
JANX Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2024 | Q4 | $490K | -- | -- | -$0.42 | -- |
| 11/06/2024 | Q3 | $1.6M | $439K | -$0.51 | -$0.36 | -$0.15 |
| 08/07/2024 | Q2 | $863.1K | $8.9M | -$0.11 | -$0.29 | $0.18 |
| 05/08/2024 | Q1 | $1M | $1.3M | -$0.30 | -$0.33 | $0.03 |
| 03/08/2024 | Q4 | $739.3K | $2.5M | -$0.24 | -$0.39 | $0.15 |
| 11/07/2023 | Q3 | -- | -- | -$0.25 | -$0.43 | $0.18 |
| 08/08/2023 | Q2 | -- | -- | -$0.42 | -$0.51 | $0.09 |
| 05/09/2023 | Q1 | -- | -- | -$0.42 | -$0.47 | $0.05 |
| 03/10/2023 | Q4 | -- | -- | -$0.39 | -$0.50 | $0.11 |
| 11/10/2022 | Q3 | -- | -- | -$0.40 | -$0.53 | $0.13 |
| 08/09/2022 | Q2 | -- | -- | -$0.41 | -$0.39 | -$0.02 |
| 05/10/2022 | Q1 | -- | -- | -$0.32 | -- | -- |
| 03/18/2022 | Q4 | -- | -- | -$0.33 | -- | -- |
| 11/09/2021 | Q3 | -- | -- | -$0.26 | -- | -- |
| 08/10/2021 | Q2 | -- | -- | -$0.62 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.06 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | -$0.13 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.10 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.20 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.11 | -- | -- |
Janux Therapeutics Earnings Questions
-
How Much did Janux Therapeutics Generate in Revenue Last Quarter?
Janux Therapeutics reported $439K worth of top line sales in its most recent quarter.
-
Did Janux Therapeutics Beat Earnings Last Quarter?
Janux Therapeutics announced earnings per share of -$0.51 which represents a miss of analyst forecast a -$0.36 per share.
-
Is Janux Therapeutics Profitable?
Janux Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Janux Therapeutics EPS Next Year?
Janux Therapeutics's earnings are forecast to decrease from -$1.32 per share to -$1.36 per share next year representing a decrease of -5.2%.
-
When is Janux Therapeutics's Earnings Date?
Janux Therapeutics's next earnings date is May 8, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 2.15% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 12.5% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 5.85% over the past day.
